Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study

References

• GovermanJAutoimmune T cell responses in the central nervous systemNat Rev Immunol20099639340719444307
   PubMed Web of Science ®Google Scholar
• RamagopalanSVDobsonRMeierUCGiovannoniGMultiple sclerosis: risk factors, prodromes, and potential causal pathwaysLancet Neurol20109772773920610348
   PubMed Web of Science ®Google Scholar
• GoodinDSThe causal cascade to multiple sclerosis: a model for MS pathogenesisPLoS One200942e456519242548
   PubMed Web of Science ®Google Scholar
• MarrieRAEnvironmental risk factors in multiple sclerosis aetiologyLancet Neurol200431270971815556803
   PubMed Web of Science ®Google Scholar
• Mc GuireCPrinzMBeyaertRvan LooGNuclear factor kappa B (NF-kappaB) in multiple sclerosis pathologyTrends Mol Med2013191060461324007818
   PubMed Web of Science ®Google Scholar
• BitschABruckWDifferentiation of multiple sclerosis subtypes: implications for treatmentCNS Drugs200216640541812027786
   PubMed Web of Science ®Google Scholar
• LublinFDReingoldSCDefining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple SclerosisNeurology19964649079118780061
   PubMed Web of Science ®Google Scholar
• D’HoogheMBNagelsGBissayVDe KeyserJModifiable factors influencing relapses and disability in multiple sclerosisMult Scler201016777378520483884
   PubMed Web of Science ®Google Scholar
• CleggABryantJImmunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectivenessExpert Opin Pharmacother20012462363911336612
   PubMedGoogle Scholar
• ChaudhuriABehanPOTreatment of multiple sclerosis: beyond the NICE guidelinesQJM200598537337815820974
   PubMed Web of Science ®Google Scholar
• JelinekGAHassedCSManaging multiple sclerosis in primary care: are we forgetting something?Qual Prim Care2009171556119281675
   PubMedGoogle Scholar
• YadavVShintoLBourdetteDComplementary and alternative medicine for the treatment of multiple sclerosisExpert Rev Clin Immunol20106338139520441425
   PubMed Web of Science ®Google Scholar
• JongenPJRuimschotelRHeeringsMImproved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational studyHealth Qual Life Outcomes2014124024646061
   PubMed Web of Science ®Google Scholar
• HadgkissEJJelinekGAWeilandTJHealth-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosisNeurol Sci201334218719522367222
   PubMed Web of Science ®Google Scholar
• McCabeMPMcKernSMcDonaldECoping and psychological adjustment among people with multiple sclerosisJ Psychosom Res200456335536115046974
   PubMed Web of Science ®Google Scholar
• FarinottiMVacchiLSimiSDi PietrantonjCBraitLFilippiniGDietary interventions for multiple sclerosisCochrane Database Syst Rev201212CD00419223235605
   PubMed Web of Science ®Google Scholar
• RiccioPThe molecular basis of nutritional intervention in multiple sclerosis: a narrative reviewComplement Ther Med201119422823721827937
   PubMed Web of Science ®Google Scholar
• JacobsDRJrGrossMDTapsellLCFood synergy: an operational concept for understanding nutritionAm J Clin Nutr20098951543S1548S19279083
   PubMed Web of Science ®Google Scholar
• JacobsDRTapsellLCFood synergy: the key to a healthy dietProc Nutr Soc201372220020623312372
   PubMed Web of Science ®Google Scholar
• WuXSchaussAGMitigation of inflammation with foodsJ Agric Food Chem201260276703671722468569
   PubMed Web of Science ®Google Scholar
• SearsBRicordiCAnti-inflammatory nutrition as a pharmacological approach to treat obesityJ Obes2011201114
   Google Scholar
• RiccioPRossanoRNutrition facts in multiple sclerosisASN Neuro201571 pii: 1759091414568185
   PubMed Web of Science ®Google Scholar
• BerksonBMRubinDMBerksonAJRevisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new casesIntegr Cancer Ther20098441642220042414
   PubMed Web of Science ®Google Scholar
• NamNHNaturally occurring NF-kappaB inhibitorsMini Rev Med Chem20066894595116918500
   PubMed Web of Science ®Google Scholar
• RamakersJDMensinkRPSchaartGPlatJArachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cellsLipids200742868769817610002
   PubMed Web of Science ®Google Scholar
• Hernandez-LahozCRodrigoLGluten-related disorders and demyelinating diseasesMed Clin (Barc)20121407314319 Spanish22998972
   PubMed Web of Science ®Google Scholar
• RodrigoLHernandez-LahozCFuentesDAlvarezNLopez-VazquezAGonzalezSPrevalence of celiac disease in multiple sclerosisBMC Neurol2011113121385364
   PubMed Web of Science ®Google Scholar
• HadjivassiliouMSandersDSGrunewaldRAWoodroofeNBoscoloSAeschlimannDGluten sensitivity: from gut to brainLancet Neurol20109331833020170845
   PubMed Web of Science ®Google Scholar
• ShorDBBarzilaiORamMGluten sensitivity in multiple sclerosis: experimental myth or clinical truth?Ann N Y Acad Sci2009117334334919758171
   PubMed Web of Science ®Google Scholar
• StefferlASchubartAStorchMButyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitisJ Immunol200016552859286510946319
   PubMed Web of Science ®Google Scholar
• MalosseDPerronHSascoASeigneurinJMCorrelation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide studyNeuroepidemiology1992114–63043121291895
   PubMed Web of Science ®Google Scholar
• ButcherJThe distribution of multiple sclerosis in relation to the dairy industry and milk consumptionN Z Med J1976835664274301067488
   PubMed Web of Science ®Google Scholar
• HamidRMasoodADietary lectins as disease causing toxicantsPak J Nutr200983293303
   Google Scholar
• RiccioPRossanoRLiuzziGMMay diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approachAutoimmune Dis2011201024984221461338
   PubMedGoogle Scholar
• MaroonJCBostJWMaroonANatural anti-inflammatory agents for pain reliefSurg Neurol Int201018021206541
   PubMedGoogle Scholar
• KiddPMNeurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative managementAltern Med Rev200510426829316366737
   PubMedGoogle Scholar
• TorkildsenOLoken-AmsrudKIWergelandSMyhrKMHolmoyTFat-soluble vitamins as disease modulators in multiple sclerosisActa Neurol Scand Suppl2013196162323190287
   PubMedGoogle Scholar
• SanoobarMDehghanPKhaliliMAzimiASeifarFCoenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trialNutr Neurosci201619313814325603363
   PubMed Web of Science ®Google Scholar
• BishtBDarlingWGShivapourETMultimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot studyDegener Neurol Neuromuscul Dis201551935
   PubMedGoogle Scholar
• McDonaldWICompstonAEdanGRecommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosisAnn Neurol200150112112711456302
   PubMed Web of Science ®Google Scholar
• BishtBDarlingWGGrossmannREA multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigueJ Altern Complement Med201420534735524476345
   PubMed Web of Science ®Google Scholar
• ValkoPOBassettiCLBlochKEHeldUBaumannCRValidation of the fatigue severity scale in a Swiss cohortSleep200831111601160719014080
   PubMed Web of Science ®Google Scholar
• KruppLBLaRoccaNGMuir-NashJSteinbergADThe fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosusArch Neurol19894610112111232803071
   PubMed Web of Science ®Google Scholar
• VickreyBGHaysRDHarooniRMyersLWEllisonGWA health-related quality of life measure for multiple sclerosisQual Life Res1995431872067613530
   PubMed Web of Science ®Google Scholar
• MyersJBaderDMadhavanRFroelicherVValidation of a specific activity questionnaire to estimate exercise tolerance in patients referred for exercise testingAm Heart J200114261041104611717610
   PubMed Web of Science ®Google Scholar
• CutterGRBaierMLRudickRADevelopment of a multiple sclerosis functional composite as a clinical trial outcome measureBrain1999122Pt 587188210355672
   PubMed Web of Science ®Google Scholar
• SolariARadiceDManneschiLMottiLMontanariEThe multiple sclerosis functional composite: different practice effects in the three test componentsJ Neurol Sci20052281717415607213
   PubMed Web of Science ®Google Scholar
• FisherJSJakAJKnikerJERudickRACutterGRAdministration and Scoring Manual for the Multiple Sclerosis Functional Composite Measure (MSFC)New York, NYDemos1999
   Google Scholar
• RaoSMLeoGJHaughtonVMAubin-FaubertPStBernardinLCorrelation of magnetic resonance imaging with neuropsychological testing in multiple sclerosisNeurology1989392 Pt 11611662915783
   PubMed Web of Science ®Google Scholar
• TombaughTNReesLBairdBKostJThe effects of list difficulty and modality of presentation on a computerized version of the Paced Serial Addition Test (PSAT)J Clin Exp Neuropsychol200426225726515202545
   PubMed Web of Science ®Google Scholar
• GoldmanMDMarrieRACohenJAEvaluation of the six-minute walk in multiple sclerosis subjects and healthy controlsMult Scler200814338339017942508
   PubMed Web of Science ®Google Scholar
• Soilu-HanninenMKoskinenJOLaaksonenMHanninenALiliusEMWarisMHigh sensitivity measurement of CRP and disease progression in multiple sclerosisNeurology200565115315516009907
   PubMed Web of Science ®Google Scholar
• SellnerJGreeveIMattleHPAtorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosisMult Scler200814798198418573823
   PubMed Web of Science ®Google Scholar
• TriantafyllouNEvangelopoulosMEKimiskidisVKIncreased plasma homocysteine levels in patients with multiple sclerosis and depressionAnn Gen Psychiatry200871718782433
   PubMedGoogle Scholar
• ZhangPDilleyCMattsonMPDNA damage responses in neural cells: focus on the telomereNeuroscience200714541439144817207936
   PubMed Web of Science ®Google Scholar
• ObeidRHerrmannWMechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementiaFEBS Lett2006580132994300516697371
   PubMed Web of Science ®Google Scholar
• OldreiveCEDohertyGHNeurotoxic effects of homocysteine on cerebellar Purkinje neurons in vitroNeurosci Lett20074131525717157438
   PubMed Web of Science ®Google Scholar
• KrumanIICulmseeCChanSLHomocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicityJ Neurosci200020186920692610995836
   PubMed Web of Science ®Google Scholar
• JhalaSSWangDHazellASThiamine deficiency results in release of soluble factors that disrupt mitochondrial membrane potential and downregulate the glutamate transporter splice-variant GLT-1b in cultured astrocytesBiochem Biophys Res Commun2014448333534124735535
   PubMed Web of Science ®Google Scholar
• JhalaSSHazellASModeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolismNeurochem Int201158324826021130821
   PubMed Web of Science ®Google Scholar
• MattsonMPSheaTBFolate and homocysteine metabolism in neural plasticity and neurodegenerative disordersTrends Neurosci200326313714612591216
   PubMed Web of Science ®Google Scholar
• KronenbergGCollaMEndresMFolic acid, neurodegenerative and neuropsychiatric diseaseCurr Mol Med20099331532319355913
   PubMed Web of Science ®Google Scholar
• ReynoldsEHMultiple sclerosis and vitamin B12 metabolismJ Neuroimmunol1992402–32252301430153
   PubMed Web of Science ®Google Scholar
• VosMEspositoGEdirisingheJNVitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiencyScience201233660861306131022582012
   PubMed Web of Science ®Google Scholar
• LiJWangHRosenbergPAVitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytesJ Neurosci Res20098791997200519235890
   PubMed Web of Science ®Google Scholar
• CarrieIPortoukalianJVicarettiRRochfordJPotvinSFerlandGMenaquinone-4 concentration is correlated with sphingolipid concentrations in rat brainJ Nutr2004134116717214704312
   PubMed Web of Science ®Google Scholar
• OhsakiYShirakawaHMiuraAVitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor kappaB through the repression of IKKalpha/beta phosphorylationJ Nutr Biochem201021111120112620149620
   PubMed Web of Science ®Google Scholar
• AchironAFeldmanAMagalashviliDDolevMGurevichMSuppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosisPLoS One2012710e4687123077530
   PubMed Web of Science ®Google Scholar
• FerlandGVitamin K and brain functionSemin Thromb Hemost201339884985524108469
   PubMed Web of Science ®Google Scholar
• SheaMKCushmanMBoothSLBurkeGLChenHKritchevskySBAssociations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of AtherosclerosisThromb Haemost2014112343844424849546
   PubMed Web of Science ®Google Scholar
• SubarAFKirkpatrickSIMittlBThe Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer InstituteJ Acad Nutr Diet201211281134113722704899
   PubMed Web of Science ®Google Scholar
• MoshfeghAJRhodesDGBaerDJThe US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakesAm J Clin Nutr200888232433218689367
   PubMed Web of Science ®Google Scholar
• GuptaSKIntention-to-treat concept: a reviewPerspect Clin Res20112310911221897887
   PubMedGoogle Scholar
• Armijo-OlivoSWarrenSMageeDIntention to treat analysis, compliance, drop-outs and how to deal with missing data in clinical research: a reviewPhys Ther Rev20091413649
   Google Scholar
• HigginsonIJHartSSilberEBurmanREdmondsPSymptom prevalence and severity in people severely affected by multiple sclerosisJ Palliat Care200622315816517058754
   PubMed Web of Science ®Google Scholar
• FiskJDPontefractARitvoPGArchibaldCJMurrayTJThe impact of fatigue on patients with multiple sclerosisCan J Neurol Sci19942119148180914
   PubMed Web of Science ®Google Scholar
• EgnerAPhillipsVLVoraRWiggersEDepression, fatigue, and health-related quality of life among people with advanced multiple sclerosis: results from an exploratory telerehabilitation studyNeuro-Rehabilitation200318212513312867675
   PubMed Web of Science ®Google Scholar
• AttarianHPBrownKMDuntleySPCarterJDCrossAHThe relationship of sleep disturbances and fatigue in multiple sclerosisArch Neurol200461452552815096400
   PubMedGoogle Scholar
• ReeseDShivapourETWahlsTLDudley-JavoroskiSDShieldsRNeuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case reportCases J20092760119918474
   PubMedGoogle Scholar
• LearmonthYCDlugonskiDPiluttiLASandroffBMKlarenRMotlRWPsychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact ScaleJ Neurol Sci20133311–210210723791482
   PubMed Web of Science ®Google Scholar
• LeeDNewellRZieglerLToppingATreatment of fatigue in multiple sclerosis: a systematic review of the literatureInt J Nurs Pract2008142819318315820
   PubMed Web of Science ®Google Scholar
• PucciEBranasPD’AmicoRGiulianiGSolariATausCAmantadine for fatigue in multiple sclerosisCochrane Database Syst Rev20071CD002818
   Google Scholar
• SchwarzSLewelingHMultiple sclerosis and nutritionMult Scler2005111243215732263
   PubMed Web of Science ®Google Scholar
• OzakbasSCagiranIOrmeciBIdimanECorrelations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosisJ Neurol Sci20042181–23714759626
   PubMed Web of Science ®Google Scholar
• KargarfardMEtemadifarMBakerPMehrabiMHayatbakhshREffect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosisArch Phys Med Rehabil201293101701170822609300
   PubMed Web of Science ®Google Scholar
• BergerJRFunctional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapiesAm J Manag Care201117Suppl 5 ImprovingS146S15321761953
   PubMedGoogle Scholar
• HabekMHojsakIBrinarVVNutrition in multiple sclerosisClin Neurol Neurosurg2010112761662020444538
   PubMed Web of Science ®Google Scholar
• FilippiMRoccaMAMRI evidence for multiple sclerosis as a diffuse disease of the central nervous systemJ Neurol2005252Suppl 5v162416254697
   PubMed Web of Science ®Google Scholar
• TomassiniVMatthewsPMThompsonAJNeuroplasticity and functional recovery in multiple sclerosisNat Rev Neurol201281163564622986429
   PubMed Web of Science ®Google Scholar
• HonGHassanMvan RensburgSJImmune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosisBr J Nutr200910291334134019454128
   PubMed Web of Science ®Google Scholar
• VrethemMMattssonEHebelkaHIncreased plasma homo-cysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acidMult Scler20039323924512814169
   PubMed Web of Science ®Google Scholar
• TeunissenCEvan BoxtelMPJollesJHomocysteine in relation to cognitive performance in pathological and non-pathological conditionsClin Chem Lab Med200543101089109516197303
   PubMed Web of Science ®Google Scholar
• TeunissenCEKillesteinJKragtJJPolmanCHDijkstraCDBlomHJSerum homocysteine levels in relation to clinical progression in multiple sclerosisJ Neurol Neurosurg Psychiatry200879121349135318676406
   PubMed Web of Science ®Google Scholar
• GoodkinDEJacobsenDWGalvezNDaughtryMSecicMGreenRSerum cobalamin deficiency is uncommon in multiple sclerosisArch Neurol19945111111011147980105
   PubMedGoogle Scholar
• RamsaransingGSFokkemaMRTeelkenAArutjunyanAVKochMDe KeyserJPlasma homocysteine levels in multiple sclerosisJ Neurol Neurosurg Psychiatry200677218919216421120
   PubMed Web of Science ®Google Scholar
• CalaCMMoseleyCESteeleCT cell cytokine signatures: biomarkers in pediatric multiple sclerosisJ Neuroimmunol20162971827397070
   PubMed Web of Science ®Google Scholar
• National Institutes of Health (NIH)Folate Dietary Supplement Fact Sheet2012 Available from: http://ods.od.nih.gov/factsheets/Folate-HealthProfessional/#h3Accessed October 23, 2014
   Google Scholar
• NIHVitamin B12 Dietary Supplement Fact Sheet2011 Available from: http://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/#h3Accessed October 23, 2014
   Google Scholar
• USDAUSDA National Nutrient Database for Standard Reference2011 Available from: http://ndb.nal.usda.gov/Accessed October 12, 2014
   Google Scholar
• SharmaSSheehyTKolonelLNEthnic differences in grains consumption and their contribution to intake of B-vitamins: results of the Multiethnic Cohort StudyNutr J2013126523688109
   PubMed Web of Science ®Google Scholar
• JacquesPFSulskySISadowskiJAPhillipsJCRushDWillettWCComparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient statusAm J Clin Nutr19935721821898424386
   PubMed Web of Science ®Google Scholar
• PufuleteMEmeryPWNelsonMSandersTAValidation of a short food frequency questionnaire to assess folate intakeBr J Nutr200287438339012064348
   PubMed Web of Science ®Google Scholar
• GreenRIndicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategiesFood Nutr Bull200829Suppl 2S52S63 discussion S64–S5618709881
   PubMed Web of Science ®Google Scholar
• PietrzikKBronstrupAVitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy populationEur J Pediatr1998157Suppl 2S135S1389587042
   PubMed Web of Science ®Google Scholar
• MacFarlaneAJShiYGreene-FinestoneLSHigh-dose compared with low-dose vitamin B-12 supplement use is not associated with higher vitamin B-12 status in children, adolescents, and older adultsJ Nutr2014144691592024699807
   PubMed Web of Science ®Google Scholar
• VogiatzoglouASmithADNurkEDietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: the Hordaland Homocysteine StudyAm J Clin Nutr20098941078108719190073
   PubMed Web of Science ®Google Scholar
• DullemeijerCSouvereinOWDoetsELSystematic review with dose-response meta-analyses between vitamin B-12 intake and European Micronutrient Recommendations Aligned’s prioritized bio-markers of vitamin B-12 including randomized controlled trials and observational studies in adults and elderly personsAm J Clin Nutr201397239040223269815
   PubMed Web of Science ®Google Scholar
• TuckerKLRichSRosenbergIPlasma vitamin B-12 concentrations relate to intake source in the Framingham Offspring studyAm J Clin Nutr200071251452210648266
   PubMed Web of Science ®Google Scholar
• LucockMWildJSmithellsRHartleyRBiotransformation of pteroylmonoglutamic acid during absorption: implications of Michaelis-Menten kineticsEur J Clin Nutr19894396316352606094
   PubMed Web of Science ®Google Scholar
• KellyPMcPartlinJGogginsMWeirDGScottJMUnmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplementsAm J Clin Nutr1997656179017959174474
   PubMed Web of Science ®Google Scholar
• KalmbachRDChoumenkovitchSFTroenAMD’AgostinoRJacquesPFSelhubJCirculating folic acid in plasma: relation to folic acid fortificationAm J Clin Nutr200888376376818779294
   PubMed Web of Science ®Google Scholar
• GarrettMHoganNLarkinASaundersJJakemanPCooteSExercise in the community for people with multiple sclerosis – a follow-up of people with minimal gait impairmentMult Scler201319679079823132904
   PubMed Web of Science ®Google Scholar
• GarrettMHoganNLarkinASaundersJJakemanPCooteSExercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trialMult Scler201319678278923128667
   PubMed Web of Science ®Google Scholar
• FarinottiMSimiSDi PietrantonjCDietary interventions for multiple sclerosisCochrane Database Syst Rev20071CD004192
   Google Scholar
• United States Census BureauEducational Attainment in the United States: 2014 – Detailed Tables2014
   Google Scholar
• BunnerAEAgarwalUGonzalesJFValenteFBarnardNDNutrition intervention for migraine: a randomized crossover trialJ Headache Pain20141516925339342
   PubMed Web of Science ®Google Scholar
• BraderLRejnmarkLCarlbergCEffects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, [corrected] controlled trial (SYS-DIET)Eur J Nutr20145341123113424570029
   PubMed Web of Science ®Google Scholar
• CrumAJLangerEJMind-set matters: exercise and the placebo effectPsychol Sci200718216517117425538
   PubMed Web of Science ®Google Scholar
• CherkinDCShermanKJAvinsALA randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back painArch Intern Med2009169985886619433697
   PubMedGoogle Scholar
• TurnerJADeyoRALoeserJDVon KorffMFordyceWEThe importance of placebo effects in pain treatment and researchJAMA199427120160916147880221
   PubMed Web of Science ®Google Scholar
• BensonHFriedmanRHarnessing the power of the placebo effect and renaming it “remembered wellness”Annu Rev Med1996471931998712773
   PubMed Web of Science ®Google Scholar
• MooreSDKingACKiernanMGardnerCDOutcome expectations and realizations as predictors of weight regain among dietersEat Behav2011121606321184975
   PubMed Web of Science ®Google Scholar